Bayer CropScience Ltd

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent downgrade in its technical trend, the stock’s mixed signals from MACD, RSI, and moving averages suggest a complex outlook for investors navigating the pesticides and agrochemicals sector.

Bayer CropScience Ltd has seen its investment rating upgraded from Sell to Hold as of 16 March 2026, reflecting a nuanced improvement across technical indicators, financial performance, valuation metrics, and overall quality. This reassessment comes amid mixed market returns and evolving company fundamentals within the pesticides and agrochemicals sector.

Bayer CropScience Ltd has experienced a subtle but notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. This change is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market sentiment for this small-cap player in the Pesticides & Agrochemicals sector.

Bayer CropScience Ltd has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent 3.04% rise in the stock price to ₹4,601.10, the overall technical outlook remains cautiously mixed, with key indicators such as MACD, RSI, and moving averages presenting divergent trends. This nuanced momentum shift warrants close attention from investors navigating the Pesticides & Agrochemicals sector.

Bayer CropScience Ltd, a key player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Hold to Sell as of 9 March 2026. This shift reflects deteriorating technical indicators, expensive valuation metrics, and subdued long-term financial growth despite recent quarterly improvements. The company’s Mojo Score has fallen to 44.0, signalling caution for investors amid a challenging market backdrop.

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s Mojo Grade was downgraded from Hold to Sell on 09 Mar 2026, reflecting deteriorating market sentiment and technical weakness. This article analyses the recent price movements, technical indicator signals, and the broader market context to provide a comprehensive view of Bayer CropScience’s current positioning.

Bayer CropScience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company's performance and outlook.

Bayer CropScience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Bayer CropScience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Bayer CropScience Ltd., a leading player in India's pesticides and agrochemicals sector, reported a dramatic recovery in profitability for Q3 FY26 (October-December 2025), with net profit surging 179.80% year-on-year to ₹95.70 crores from ₹34.20 crores in the corresponding quarter last year. However, the quarter-on-quarter performance tells a different story, with net profit declining 37.33% from ₹152.70 crores in Q2 FY26, primarily driven by a sharp 28.79% sequential revenue contraction. The ₹21,247-crore market cap company's shares have gained 5.13% year-to-date, though they remain 26.69% below their 52-week high of ₹6,539.95.

Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Bayer CropScience Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest daily gain of 0.98%, the stock’s overall technical profile remains cautiously bearish, with key indicators such as MACD and moving averages signalling a mild deterioration in trend strength. This analysis delves into the recent technical parameter changes, contextualising them within the broader market environment and the company’s performance relative to the Sensex.

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend despite some mildly bullish weekly signals. The stock’s recent price action and technical parameters suggest increased caution for investors amid a challenging market backdrop for the pesticides and agrochemicals sector.

Bayer CropScience Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent 2.62% intraday gain to ₹4,480, the stock’s overall technical indicators suggest a cautious outlook, with a downgrade in its Mojo Grade from Hold to Sell signalling increased investor scepticism.

Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.